|
|
Pharma Mar S.A.
BME •
Healthcare •
Biotechnology •
Quote as of 06/09/2026 17:35
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeBME
Market Capitalization1,727.97 mln
Float13.43 mln
Earnings Date04/29/2026
P / E
18.23
Moderately valued
1-Year Forecast
109
Strong upside
Key Fundamentals
EPS4.62
P/E18.23
ROE33.54
RPS14.92
ROIC34.45
ROA20.05
Interest Cover19.12
EBITDA, mln68.54
EV / EBITDA22.18
EV / EBIT25.98
Revenue, mln259
EV / Revenue5.86
Financial Strength
Altman Z-Score9.41
Piotroski F-Score
6
/ 9
Beneish M-Score-2.02
Price to Intrinsic Value2.47
Price to Graham Number2.77
1-Year Target Price109
Shiller PE Ratio50.93
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-12.84% |
3
/ 100
 |
| 1 Month |
-16.45% |
5
/ 100
 |
| 2 Months |
-0.48% |
48
/ 100
 |
| 6 Months |
10.99% |
62
/ 100
 |
| 1 Year |
1.23% |
41
/ 100
 |
|
| |
